Spear Bio logo

Business Development Manager, Immunoassays & Biomarkers (Southeast)

Spear Bio

Raleigh-Durham, NC; Charleston, SC; Birmingham, ALOnsitePosted 12 days ago$160,000 - $180,000/year
Full TimeSenior LevelCommercial & Pharma SalesBiotechnology
Original posting ↗

Summary

Spear Bio is seeking top-performing Business Development Managers to introduce our high-performance and expanding portfolio of ultra-sensitive Immunoassays to the Life Sciences and CRO markets. We are hiring individuals based in the Southeast (North Carolina, South Carolina, Tennessee, Alabama, Georgia, Florida) with a deep network of neurodegenerative disease research customers in Big Pharma, Biotech, CROs, & Academic throughout the Southeast region.

Job description

Position Summary

Spear Bio is seeking top-performing Business Development Managers to introduce our high-performance and expanding portfolio of ultra-sensitive Immunoassays to the Life Sciences and CRO markets. We are hiring individuals based in the Southeast (North Carolina, South Carolina, Tennessee, Alabama, Georgia, Florida) with a deep network of neurodegenerative disease research customers in Big Pharma, Biotech, CROs, & Academic throughout the Southeast region.

Key Responsibilities

  • Deliver sales presentations to clients to promote the value proposition of Spear Bio.
  • Demonstrate deep understanding of Neuroscience market dynamics and technology adoption which positions Spear Bio as a superior, best-in-class solution.
  • Promote our kit sales by providing various instrument and Assay Service solutions to generate ongoing market adoption and revenue growth.
  • Provide a funnel to be managed by senior Business Development Managers.
  • Be on-point for all customer logistics and follow up: Demos, information sharing, and other key technical details requested to engage our customers.
  • Utilize your existing network of high-level scientific customers within Big Pharma, Biotech, CROs, & Academic market segments, as well as knowledge of IVD markets including LDTs.
  • Achieve a consistent track record exceeding quotas, revenue targets, and increasing market share in your primary territory/region.
  • Provide technical support to many of our Key Opinion Leaders throughout the US/EMEA.
  • Work closely with our internal Marketing team and contribute to driving lead generation programs that can enhance our outreach in all regions.
  • Work closely with our Assay Services leader to support funnel building of this area, as well as provide Voice of Customer (VOC) feedback to our R&D teams on market dynamics gained with our commercial activity.
  • Jointly build a sales plan with personal and professional goals that will provide the best metrics for success in the role.
  • Provide regular updates on activity, forecasting, and funnel movement to assist in the transparency of activity driving strong revenue outcomes.
  • Apply insight on current competitive landscape to develop strategies enabling Spear Bio to win in a competitive market where we have a strong scientific advantage.
  • Approximately 30-40% travel expected directly with customers and/or partners to achieve the sales results expected.

Required Qualifications

  • MS or PhD in Biology, Biochemistry, Bioengineering or related field with 4-10+ years of an established track record in sales or business development, presenting ultrasensitive immunoassays or neurology IVD products to customers.
  • Clear and pro-active communicator with advanced commercial sales acumen, high energy, a strong work ethic, and a bias for action.
  • Ability to ask the right questions of potential customers to then strategically communicate how Spear Bio's differentiated technology and performance will directly benefit them over the competition.
  • Ability to clearly present technology solutions in a way that leads to strong revenue outcomes.
  • Ability to translate observations and customer feedback into strategy.
  • Comfortable providing and receiving feedback designed to improve engagement and results.
  • Ability to collaborate within a best-in-class team environment comprised of Field Application functions, Assay Services, and others.
  • Willingness to travel up to 30-40% for customer engagement and industry events.

Requirements

  • MS or PhD in Biology, Biochemistry, Bioengineering or related field
  • 4-10+ years of established track record in sales or business development
  • Experience presenting ultrasensitive immunoassays or neurology IVD products to customers
  • Clear and pro-active communicator with advanced commercial sales acumen
  • High energy, strong work ethic, and bias for action
  • Ability to ask the right questions of potential customers and strategically communicate differentiated technology value
  • Ability to clearly present technology solutions leading to strong revenue outcomes
  • Ability to translate observations and customer feedback into strategy
  • Comfortable providing and receiving feedback
  • Ability to collaborate within a team environment
  • Willingness to travel up to 30-40%

Benefits

  • Competitive compensation
  • Meaningful stock ownership
  • Comprehensive benefits

Company overview

Spear Bio is an innovative biotechnology company founded in 2021 and headquartered in Woburn, Massachusetts. The company specializes in developing ultra-sensitive protein biomarker detection technology for research and diagnostic applications. Spear Bio's proprietary Successive Proximity Extension Amplification Reaction (SPEAR) technology employs a unique 2-factor authentication mechanism to precisely measure protein biomarkers at attomolar levels from sub-microliter sample volumes. This breakthrough technology enables unprecedented sensitivity in detecting low-abundance biomarkers, particularly valuable for neurodegenerative disease research and early disease diagnosis. The company's SPEAR UltraDetect™ assays focus on neurological biomarkers including pTau 217, pTau 231, GFAP, and Neurofilament Light chain, with applications in Alzheimer's disease, traumatic brain injury, and other neurological conditions. Spear Bio recently secured FDA Breakthrough Device Designation for its pTau 217 blood test and raised $45 million in Series A funding to accelerate product commercialization and expand its biomarker menu.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.